|
[1]YANG L,YUE S,YANG L,et al.Sphingosine kinase/sphingosine1-phosphate(S1P)/S1P receptor axis is involved in liver fibrosis-associated angiogenesis[J].J Hepatol,2013,59(1):114-123.
|
|
[2]NAVARI M,ZARE M,JAVANMARDI M,et al.The diagnosis and treatment of brain metastases in EGFR mutant lung cancer[J].Immunopharmacol Immunotoxicol,2014,29:1-7.
|
|
[3]YASHIMA H,SHIMIZU K,ARAKI T,et al.EGFR mutations and clinical outcomes of chemotherapy for advanced non-small cell lung cancer:a meta-analysis[J].Mol Clin Oncol,2014,2(5):714-718.
|
|
[4]STANIC K,ZWITTER M,HITIJ NT,et al.Lupeol induces apoptosis and inhibits invasion in gallbladder carcinoma GBC-SD cells by suppression of EGFR/MMP-9 signaling pathway[J].Radiol Oncol,2014,48(2):173-183.
|
|
[5]BRUIX J,SHERMAN M,LLOVET JM,et al.Clinical management of hepatocellular carcinoma.Conclusions of the Barcelona-2000 EASL conference.European Association for the Study of the Liver[J].J Hepatol,2001,35(3):421-430.
|
|
[6]European Association for Study of Liver,European Organisation for Research and Treatment of Cancer.EASL-EORTC clinical practice guidelines:management of hepatocellular carcinoma[J].Eur J Cancer,2012,48(5):599-641.
|
|
[7]FRACHON S,GOUYSSE G,DUMORTIER J,et al.Endothelial cell marker expression in dysplastic lesions of the liver:an immuno-histochemical study[J].J Hepatol,2001,34(6):850-857.
|
|
[8]CHUANG CH,LIU CH,LU TJ,et al.Suppression of alpha-tocopherol ether-linked acetic acid in VEGF-induced angiogenesis and the possible mechanisms in human umbilical vein endothelial cells[J].Toxicol Appl Pharmacol,2014,281(3):310-316.
|
|
[9]LIU Y,WANG CZ,LIU MH,et al.Research progress of VEGF/VEGFR signaling pathway in targeted therapy of liver cancer[J].Chin J Immunol,2013,29(1):97-101.(in Chinese)刘尧,王长振,刘明华,等.VEGF/VEGFR信号转导通路在肝癌靶向治疗中的研究进展[J].中国免疫学杂志,2013,29(1):97-101.
|
|
[10]UMEGUCHI H,SUEOKA-ARAGANE N,KOABYASHI N,et al.Usefulness of plasma HGF level for monitoring acquired resistance to EGFR tyrosine kinase inhibitors in non-small cell lung cancer[J].Oncol Rep,2015,33(1):391-396.
|
|
[11]NOUR S,MONNER M,BIKFALVI A.Recent developments in the regulation of the angiogenic switch by cellulars tress factors in tumors[J].Cancer Lett,2005,218(1):1-14.
|
|
[12]LIU Y,POON RT,LI Q,et al.Both an tiangiogen es is-and angio-genesis-independent effects are responsible for hepatocellular carcinoma growth arrest by tyrosine kinase inhibitor PTK787/ZK222584[J].Cancer Res,2005,65(9):3691-3699.
|
|
[13]RASKOPF E,VOGT A,SAUERBRUCH T,et al.SiRNA targeting VEGF inhibits hepatocellular carcinoma growth and tumor angiogenesis in vivo[J].J Hepatol,2008,49(6):977-984.
|
|
[14]NAKAMURA K,ZEN Y,SATO Y,et al.Vascular endothelial growth factor,its receptor Flk-1,and hypoxia inducible factor-1alpha are involved in malignant transformation in dysplastic nodules of the liver[J].Hum Pathol,2007,38(10):1532-1546.
|
|
[15]KOH SA,KIM MK,LEE KH,et al.Rho GDI2 is associated with HGFmediated tumor invasion through VEGF in stomach cancer[J].Clin Exp Metastasis,2014,31(7):805-815.
|
|
[16]NAKADE J,TAKEUCHI S,NAKAGAWA T,et al.Triple inhibition of EGFR,Met,and VEGF suppresses regrowth of HGF-triggered,erlotinib-resistant lung cancer harboring an EGFR mutation[J].J Thorac Oncol,2014,9(6):775-783.
|
|
[17]CAMPBELL JS,HUGHES SD,GILBERTSON DG,et al.Plateletderived growth factor induces liver fibrosis,steatos is,and hepatocellular carcinoma[J].Proc Natl Acad Sci U S A,2005,102(9):3389-3394.
|
|
[18]YU D,SUN X,QIU Y,et al.Identification and clinical signifcance of mobilized endothelial progenitor cells in tumor vasculor genesis of hepatocellular carcinoma[J].Clin Cancer Res,2007,13(13):3814-3824.
|
|
[19]ABDEL-RAHMAN O.Vascular endothelial growth factor(VEGF)pathway and neuroendocrine neoplasms(NENs):prognostic and therapeutic considerations[J].Tumour Biol,2014,35(11):10615-10625.
|
|
[20]SHARMA PS,SHARMA R,TYAGI T,et al.VEGF/VEGFR pathway inhibitors as anti-angiogenic agents:present and future[J].Curr Cancer Drug Targets,2011,11(5):624-653.
|
DownLoad: